Infantile hemangiomas (IHs) are common neoplasms composed of proliferating endothelial-
like cells. Despite the relative frequency of IH and the potential severity of complications …

We review recent advances in the use of corticosteroids (CS) in pediatric lung disease. CS
are frequently used, systemically or by inhalation. Their mechanisms of action in pulmonary …

Infantile hemangiomas (IHs) are the most common tumors of childhood. Unlike other tumors,
they have the unique ability to involute after proliferation, often leading primary care …

Propranolol has recently emerged as an effective therapy for infantile hemangiomas causing
regression. The β-adrenergic receptor (AR) antagonist is thought to cause vasoconstriction …

Aims Propranolol may have shown excellent results as a first line therapy in infantile
haemangiomas (IHs) at all sites in the body, but this conclusion remains controversial. In an …

Background The success of oral propranolol for treatment of infantile hemangiomas (IHs)
has led practitioners to use topical β‐blockers. In preterm infants, clinicians frequently turn to …

Propranolol and timolol are nonselective ß‐adrenergic antagonists that induce peripheral
vasoconstriction and affect angiogenic cytokines. Oral and topical ß‐blocker therapy has …

OBJECTIVE: To study the effectiveness of propranolol in infantile airway haemangiomas
and compare the effectiveness of propranolol vs. different therapies. METHODS: A literature …

Infantile hemangiomas are the most common vascular tumors of infancy. A multidisciplinary
approach including dermatologists, otolaryngologists, plastic surgeons, hematologists …

Vascular anomalies represent a broad range of vascular malformations and tumors, which
predominantly occur in the head and neck and are seen in approximately 4.5% of children. 1 …